-
Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)
Tuesday, July 2, 2013 - 8:58am | 628Read More...Things are starting to heat up in the already hot pharmaceutical sector – especially as it relates to mergers and acquisitions. Only days after Onyx Pharmaceuticals (NASDAQ: ONXX) said it rejected an $8.7 billion buyout offer from Amgen (NASDAQ: AMGN), according to Reuters, the company has...
-
J.P. Morgan Maintains Rating, PT Following Presentation By ARIA
Tuesday, June 7, 2011 - 7:36am | 132Read More...J.P. Morgan is maintaining its Overweight rating, along with its $10 price target on Ariad Pharmaceuticals (NASDAQ: ARIA) following the company's recent presentation at the ASCO Conference. Says J.P. Morgan, in its report, “We reiterate our OW rating on ARIA following presentations yesterday...
